MedTrace Logo

A Study for Moderate Osteoarthritis of the Knee

NCT01478997 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2012-05-16

No results posted yet for this study

Summary

This is a study to determine whether Flexsure is Safe, Tolerable and Effective in relieving symptoms of Moderate Osteoarthritis of the Knee.

Conditions

Interventions

DIETARY_SUPPLEMENT

Flexsure Capsules

Flexsure - 3 capsules once a day in the absence of meals (at least 30 min prior to meals) for 56 days

DIETARY_SUPPLEMENT

Placebo Capsules

Carboxy Methyl Cellulose

Sponsors & Collaborators

  • VitalgNetics

    collaborator UNKNOWN

  • Vedic Lifesciences Pvt. Ltd.

    lead INDUSTRY

Principal Investigators

  • Dr. Bhakti Shinde, BAMS, PGDCR · Vedic Lifesciences Pvt. Ltd.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2012-03-31
Completion
2012-03-31

Countries

  • India

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01478997 on ClinicalTrials.gov